The IMPACT study (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in men at higher genetic risk and controls) is an international, multicentre study evaluating the role of targeted PSA screening in men with BRCA1/2 mutations 6. This evidence concerns the gene BRCA1 and prostate cancer.